Inhibition of Mycobacterium tuberculosis-Induced Signalling by Transforming Growth Factor-β in Human Mononuclear Phagocytes

Scandinavian Journal of Immunology

Volumn 75, Issue 3, 2012, Pages 301-304

  Wu, M ^a   Aung, H ^a   Hirsch, C S ^a   Toossi, Z ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CLARITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; PLASMIN; PLASMINOGEN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UROKINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION;

BENZAMIDES; DIOXOLES; HUMANS; ISOQUINOLINES; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTES; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; PYRIDINES; PYRROLES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS;

EID: 84856944002     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02668.x     Document Type: Article

References (15)

1. Toossi Z, Ellner JJ. The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol 1998;87:107-14.
2. Aung H, Toossi Z, McKenna SM et al. Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber Lung Dis 2000;80:61-7.
3. Bonecini-Almeida MG, Ho JL, Boechat N et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004;72:2628-34.
4. Wilkinson KA, Martin TD, Reba SM et al. Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during mycobacterium bovis BCG infection in C57BL/6 mice. Infect Immun 2000;68:6505-8.
5. Aung H, Wu M, Johnson JL, Hirsch CS, Toossi Z. Bioactivation of latent transforming growth factor beta1 by Mycobacterium tuberculosis in human mononuclear phagocytes. Scand J Immunol 2005;61:558-65.
6. Roberts AB. TGF-beta signaling from receptors to the nucleus. Microbes Infect 1999;1:1265-73.
7. Laping NJ, Grygielko E, Mathur A et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002;62:58-64.
8. Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol 2006;69:597-607.
9. Yu C, Azuma A, Li Y et al. EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts. Exp Lung Res 2008;34:343-54.
10. Khalil N. TGF-beta: from latent to active. Microbes Infect 1999;1:1255-63.
11. Lund LR, Ellis V, Ronne E, Pyke C, Dano K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem J 1995;310 (Pt 1):345-52.
12. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis 1994;170:1229-37.
13. Schwander SK, Torres M, Sada E et al. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 1998;178:1434-45.
14. Park SI, Zhang J, Phillips KA et al. Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Res 2008;1:68.
15. DaCosta Byfield S, Major C, Laping NJ, Roberts AB. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2004;65:744-52.